Cytokinetics (CYTK) Competitors $38.56 -1.25 (-3.14%) Closing price 04:00 PM EasternExtended Trading$38.72 +0.16 (+0.43%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CYTK vs. TEVA, ITCI, SMMT, GMAB, RDY, MRNA, VTRS, QGEN, ASND, and ROIVShould you be buying Cytokinetics stock or one of its competitors? The main competitors of Cytokinetics include Teva Pharmaceutical Industries (TEVA), Intra-Cellular Therapies (ITCI), Summit Therapeutics (SMMT), Genmab A/S (GMAB), Dr. Reddy's Laboratories (RDY), Moderna (MRNA), Viatris (VTRS), Qiagen (QGEN), Ascendis Pharma A/S (ASND), and Roivant Sciences (ROIV). These companies are all part of the "pharmaceutical products" industry. Cytokinetics vs. Teva Pharmaceutical Industries Intra-Cellular Therapies Summit Therapeutics Genmab A/S Dr. Reddy's Laboratories Moderna Viatris Qiagen Ascendis Pharma A/S Roivant Sciences Teva Pharmaceutical Industries (NYSE:TEVA) and Cytokinetics (NASDAQ:CYTK) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, earnings, risk, media sentiment, valuation, community ranking, analyst recommendations and institutional ownership. Is TEVA or CYTK more profitable? Teva Pharmaceutical Industries has a net margin of -9.91% compared to Cytokinetics' net margin of -17,906.25%. Teva Pharmaceutical Industries' return on equity of 42.46% beat Cytokinetics' return on equity.Company Net Margins Return on Equity Return on Assets Teva Pharmaceutical Industries-9.91% 42.46% 6.65% Cytokinetics -17,906.25%N/A -50.21% Does the media refer more to TEVA or CYTK? In the previous week, Teva Pharmaceutical Industries had 3 more articles in the media than Cytokinetics. MarketBeat recorded 21 mentions for Teva Pharmaceutical Industries and 18 mentions for Cytokinetics. Teva Pharmaceutical Industries' average media sentiment score of 1.08 beat Cytokinetics' score of 0.71 indicating that Teva Pharmaceutical Industries is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teva Pharmaceutical Industries 15 Very Positive mention(s) 4 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cytokinetics 8 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Positive Does the MarketBeat Community prefer TEVA or CYTK? Teva Pharmaceutical Industries received 514 more outperform votes than Cytokinetics when rated by MarketBeat users. However, 79.92% of users gave Cytokinetics an outperform vote while only 67.82% of users gave Teva Pharmaceutical Industries an outperform vote. CompanyUnderperformOutperformTeva Pharmaceutical IndustriesOutperform Votes133467.82% Underperform Votes63332.18% CytokineticsOutperform Votes82079.92% Underperform Votes20620.08% Which has preferable valuation & earnings, TEVA or CYTK? Cytokinetics has lower revenue, but higher earnings than Teva Pharmaceutical Industries. Teva Pharmaceutical Industries is trading at a lower price-to-earnings ratio than Cytokinetics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTeva Pharmaceutical Industries$16.54B0.94-$1.64B-$1.45-9.47Cytokinetics$18.47M250.52-$526.24M-$5.26-7.38 Do analysts prefer TEVA or CYTK? Teva Pharmaceutical Industries currently has a consensus price target of $23.43, indicating a potential upside of 70.58%. Cytokinetics has a consensus price target of $82.00, indicating a potential upside of 111.17%. Given Cytokinetics' stronger consensus rating and higher probable upside, analysts plainly believe Cytokinetics is more favorable than Teva Pharmaceutical Industries.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Teva Pharmaceutical Industries 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86Cytokinetics 0 Sell rating(s) 2 Hold rating(s) 15 Buy rating(s) 1 Strong Buy rating(s) 2.94 Which has more risk & volatility, TEVA or CYTK? Teva Pharmaceutical Industries has a beta of 0.72, suggesting that its stock price is 28% less volatile than the S&P 500. Comparatively, Cytokinetics has a beta of 0.94, suggesting that its stock price is 6% less volatile than the S&P 500. Do insiders & institutionals believe in TEVA or CYTK? 54.0% of Teva Pharmaceutical Industries shares are owned by institutional investors. 0.6% of Teva Pharmaceutical Industries shares are owned by company insiders. Comparatively, 3.4% of Cytokinetics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. SummaryCytokinetics beats Teva Pharmaceutical Industries on 10 of the 19 factors compared between the two stocks. Remove Ads Get Cytokinetics News Delivered to You Automatically Sign up to receive the latest news and ratings for CYTK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CYTK vs. The Competition Export to ExcelMetricCytokineticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.61B$6.38B$5.36B$7.63BDividend YieldN/A3.23%5.11%4.33%P/E Ratio-7.206.8721.7617.88Price / Sales250.52228.44381.6595.73Price / CashN/A65.6738.1534.64Price / Book-9.865.886.484.02Net Income-$526.24M$141.59M$3.20B$247.22M7 Day Performance12.33%9.94%6.97%7.00%1 Month Performance-12.46%-11.97%-8.33%-6.42%1 Year Performance-42.90%-11.67%10.06%-0.03% Cytokinetics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CYTKCytokinetics3.7824 of 5 stars$38.56-3.1%$81.63+111.7%-44.4%$4.60B$18.47M-7.17250Analyst ForecastGap DownTEVATeva Pharmaceutical Industries3.0181 of 5 stars$13.91+0.8%$23.43+68.5%+2.1%$15.77B$16.54B-9.5936,800Analyst DowngradeOptions VolumePositive NewsITCIIntra-Cellular Therapies3.495 of 5 stars$131.87flat$106.23-19.4%N/A$14.05B$680.50M-151.57560Analyst ForecastPositive NewsSMMTSummit Therapeutics2.6205 of 5 stars$17.32-0.2%$35.40+104.4%+613.0%$12.78B$700,000.00-61.85110News CoverageGMABGenmab A/S4.2162 of 5 stars$18.19-1.1%$41.33+127.2%-34.0%$12.04B$21.53B10.451,660Short Interest ↓Gap DownHigh Trading VolumeRDYDr. Reddy's Laboratories3.3658 of 5 stars$12.59+1.8%$17.00+35.1%-7.2%$10.51B$311.31B20.0424,800Positive NewsHigh Trading VolumeMRNAModerna4.3298 of 5 stars$25.64+2.1%$59.00+130.1%-74.5%$9.91B$3.20B-2.763,900Positive NewsVTRSViatris2.963 of 5 stars$7.61-0.1%$10.50+38.0%-32.7%$9.08B$14.74B-10.2837,000News CoverageHigh Trading VolumeQGENQiagen3.4768 of 5 stars$40.33+5.4%$47.71+18.3%+8.3%$8.96B$1.98B112.296,030High Trading VolumeASNDAscendis Pharma A/S2.3124 of 5 stars$140.14-1.8%$204.64+46.0%+6.5%$8.50B$363.64M-19.741,017News CoveragePositive NewsROIVRoivant Sciences2.6217 of 5 stars$9.26-2.1%$17.50+89.0%-6.9%$6.61B$122.59M-61.73860Positive NewsHigh Trading Volume Remove Ads Related Companies and Tools Related Companies Teva Pharmaceutical Industries Alternatives Intra-Cellular Therapies Alternatives Summit Therapeutics Alternatives Genmab A/S Alternatives Dr. Reddy's Laboratories Alternatives Moderna Alternatives Viatris Alternatives Qiagen Alternatives Ascendis Pharma A/S Alternatives Roivant Sciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CYTK) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytokinetics, Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Cytokinetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CYTK Stock Free CYTK Stock Alerts